Local inflammation elicited by Neisseria gonorrhoeae correlates closely with sensitivity to killing by normal human serum. Serum-sensitive (SS) isolates are rendered resistant in vitro by lipooligosaccharide sialylation. Differences in C3b processing on N. gonorrhoeae in vitro were found to match findings at the cervical level in vivo. Nonsialylated SS gonococci bound 5-fold more C3b than did stably serum-resistant (SR) gonococci; most was processed to iC3b, yet significant C3b persisted. Sialylated SS gonococci bound 4-fold less total C3 antigen than did SR gonococci, which was promptly converted to iC3b. C3b bound later on stably SR gonococci but again was processed swiftly to iC3b. In vivo, the iC3b/C3 ratio of SS isolates more closely resembled nonsialylated SS isolates in vitro, implying heterogeneous sialylation or desialylation in vivo. In vitro, total IgM bound was unchanged by sialylation of SS isolates, but total C4 bound decreased by 75%, suggesting that sialylation may indirectly regulate the classical complement pathway.
Human infection caused by Neisseria gonorrhoeae encompasses a wide range of clinical syndromes, including the total absence of signs and symptoms at the primary or local site of infection (e.g., genital or pharyngeal) often seen in disseminated gonococcal infection [1, 2] and the marked local inflammatory response seen in acute salpingitis or pelvic inflammatory disease [3] . The inflammatory potential of gonococci at the local site of infection has been linked to the ability of the organism to resist the complement-dependent bactericidal action of normal human serum (NHS) [3] . Serum resistance is most commonly exhibited by isolates (SR isolates) causing disseminated gonococcal infection and may be a mechanism that enables these organisms to evade local defenses and enter the bloodstream. Stably SR isolates may persist at local sites without evoking clinically significant local inflammation [1] . In contrast, serumsensitive (SS) gonococci are commonly isolated from patients with acute and severe local inflammation and pelvic inflammatory disease [3] . Previous investigations have demonstrated that SS isolates more rapidly generate the chemotactic com-plement fragment C5a [4] and are more quickly and completely phagocytosed by neutrophils in vitro than stably SR isolates [5] . This response serves to contain the infection locally. This suggests that stably SR isolates may use mechanisms that diminish the formation and/or activity of the C5 convertase to limit the local inflammatory response and thereby facilitate dissemination. Such stably SR gonococcal isolates appear to inactivate C3b to iC3b more quickly than do SS gonococci in NHS [6] .
C3 fragments that attach to surfaces through ester bonds can be released by use of nucleophiles such as hydroxylamine and methylamine [7, 8] . Qualitative examination of such C3 fragments released from both SR and SS (sialylated or not) gonococci has shown a predominance of iC3b over C3b at opsonization times up to 60 min [6, 9] . We studied two prototypic gonococcal isolates in vitro to define early events in the opsonization period that may contribute more directly to serum resistance than are shown by measurements obtained after more prolonged opsonization periods. Having established a baseline with prototypic gonococcal isolates, we extended our results using gonococci isolated from 16 infected women. We sought to investigate the hypothesis that in vivo sialylation of gonococci is heterogeneous, as observed by others [10] .
determine the sensitivity of these isolates (and their sialylated variants, see below) to 50% NHS. Eight SS and 8 SR clinical (cervical) isolates [13] were randomly chosen from women identified as contacts of men with gonorrhea. Porin protein (Por) subclass typing (J. Knapp, CDC, Atlanta) was done on both SS (3 Por1A, 5 Por1B) and SR (4 Por1A, 4 Por1B) isolates. Secretions infected with gonococci were obtained by cervical saline lavage (5 mL of saline was directed against the cervical os by use of an angio-cath [16 gauge, 5 cm; Pharmacia, Piscataway, NJ]; lavage fluid was aspirated and redirected against the cervical os twice more, then withdrawn into a 5-mL luerlock syringe) and stored at Ϫ80ЊC until use. Three prototypic laboratory gonococcal isolates, 24-1 (SS, isolated from a patient with pelvic inflammatory disease [14] ) and 71-H and WG (SR, isolated from patients with disseminated gonococcal infection [15, 16] ), along with SR isolates 8551 [17] , NRL (Neisseria Reference Laboratory) 31797 (group II-no. 19; [2] ), NRL 31800 (group I-no. 5, [2] ), 71H [15] , JW31, NRL 32065 [2] , and group II-no. 45 [1] , were used to generate standard curves relating optical density to number of organisms in an ELISA designed to quantitate the number of organisms in cervical secretions (see below [in vivo]). SR gonococcal isolate 252 (1 of the 8 clinical strains above) and SS isolate 24-1 were chosen as prototypes for the in vitro C3 kinetic experiments described below. Gonococcal isolate 15253 (SR, isolated from a patient with disseminated gonococcal infection [18] ) was used as a target for C3b and iC3b in experiments to test the specificity of the anti-C3 monoclonal antibodies (MAbs; see below).
To achieve maximal in vitro sialylation of organisms, isolates were grown on plates flooded with 5 -monophospho-N-acetyl neuraminic acid (CMP-NANA; 80 mg/mL in PBS) [19] . Growth of gonococci in media containing CMP-NANA leads to gonococcal lipooligosaccharide (LOS) sialylation and converts SS gonococci to SR gonococci in concomitant bactericidal assays with 50% NHS [19, 20] . The relative amount of CMP-NANA incorporated by the isolates was assessed by incorporation of 3 H-labeled CMP-NANA followed by scintillation counting and tricine SDS-PAGE fluorography [21] .
Sera and complement. NHS was obtained fresh from 11 normal adults who had no history of neisserial infection, pooled (PNHS), and stored at Ϫ80ЊC until use in bactericidal and C3 binding assays. NHS immunodepleted of C3 (Advanced Research Technologies, San Diego) regained full hemolytic activity on addition of functional C3, which was purified by a modification of established methods [22] . C3 was labeled with 125 I by use of Iodobeads (Pierce Chemical, Rockford, IL) to a specific activity of cpm/mg. 5 7.1 ϫ 10 Complement components C3, C3b, iC3b, C4, and factor B (Advanced Research Technologies) and immunoglobulins IgG, IgA, and IgM (Sigma, St. Louis) were purchased for generation of standard curves (see below).
Specific monoclonal and polyclonal antibodies. For the whole cell ELISA (see below [in vitro]), murine MAb directed against C3b (MAb C-5G, IgG1k) and iC3b (MAb G-3E, IgG2bk) (gifts of K. Iida [23] ), polyclonal goat anti-human C3 (Cappel/ICN Biopharmaceuticals, Costa Mesa, CA), polyclonal goat anti-human C4 (Scripps Laboratories, San Diego), and polyclonal sheep antihuman factor B (IgG fraction; Cortex Biochem, San Leandro, CA) were used to detect their respective complement fragment targets. Affinity-purified goat anti-human IgG and anti-human IgA (whole molecules) and anti-human IgM (m-chain-specific) antibodies (Sigma) and anti-murine immunoglobulin secondary antibodies (Sigma) were used conjugated to alkaline phosphatase for the whole cell ELISA (in vitro). Murine MAb 2C3 (IgG1k) recognizes the conserved gonococcal H.8 lipoprotein antigen [10] and was used as a basis for the capture of gonococci from cervical secretions. In this capture ELISA (see below [in vivo]), goat polyclonal antibody directed against C3, C4, and factor B and MAb directed against iC3b neoantigen (IgG2bk) [24] were purchased conjugated to horseradish peroxidase (Quidel, San Diego) and used to detect complement antigens on the surface of captured gonococci. Affinity-purified goat anti-human IgG and anti-human IgA (whole molecules) and anti-human IgM (m-chain-specific) antibodies (Sigma) were used conjugated to horseradish peroxidase in the organism capture ELISA (in vivo).
Buffers. A buffer consisting of 0.1 M phosphate buffer, 0.11 M NaCl, 0.56% bovine serum albumin (fraction V; Sigma), 0.35% Triton X-100, and 0.05% thimerosal, pH 7.2, was used as the standard buffer for capture of organisms from cervical secretions (capture assay buffer [in vivo]). Hanks' balanced salt solution containing 1 mM MgCl 2 and 0.15 mM CaCl 2 (HBSS ϩϩ ) and HBSS ϩϩ with 0.1% gelatin (Difco Laboratories, Detroit) added (gel-HBSS ϩϩ ) were the standard buffers used in plate ELISAs (in vitro).
C3 binding determined directly with radiolabeled C3. Gonococci were grown overnight on plates in candle extinction jars at 37ЊC followed by growth in liquid media [25] to log phase. After two washes in HBSS ϩϩ , the organisms were suspended ( /mL) 8 0.5 ϫ 10 in gel-HBSS ϩϩ (total volume, 1 mL) either containing 10% NHS immunodepleted of C3 (Advanced Research Technologies) supplemented with trace amounts of 125 I-labeled C3 ( 125 I-C3) or containing 10% PNHS (for Western blot experiments). The reaction mixtures were incubated at 37ЊC for 5, 10, 30, and 60 min with shaking, and then duplicate 200-mL aliquots were removed and immediately layered on top of 500 mL of ice-cold gel-HBSS ϩϩ , followed by centrifugation at 14,000 g (Beckman microfuge II; Beckman Instruments, Palo Alto, CA) at 4ЊC for 5 min. The pellets were resuspended in 500 mL of ice-cold gel-HBSS ϩϩ followed by repeat centrifugation to separate pellets from nonassociated 125 I-C3. Gamma emissions from the pellets were counted (LKB-Wallac 1282 Compugamma; Pharmacia LKB Nuclear, Gaithersburg, MD) to determine total C3 bound (molecules/organism). Colony-forming units were concomitantly determined by plating of the organism suspensions. The number of C3 molecules bound per organism was calculated as (total counts in pellet/counts per molecule of 125 I-C3)/ no. of organism in pellet. The pellets were then solubilized in SDS sample buffer containing 90 mM dithiothreitol for 10 min at 100ЊC or incubated with methylamine as detailed below. Samples were stored, after solubilization, at Ϫ80ЊC until analyzed by SDS-PAGE (see below).
Validation of specificity of anti-iC3b and -C3b MAbs. The specificities of the anti-iC3b neoantigen MAb (Quidel) [24] , anti-iC3b MAb G-3E [23] , and anti-C3b MAb C-5G [23] were tested for C3b and iC3b bound to N. gonorrhoeae isolate 15253. Gonococci ( organisms) were suspended (final volume, 50 mL in 9 2 ϫ 10 HBSS ϩϩ ) with 10 mg of preformed cobra venom factor (CVF),Bb C3 convertase [26] (gift of M. Pangburn, University of Texas Health Science Center, Tyler) and C3 (25 mg) and incubated at 37ЊC for 20 min to generate C3b-organism complexes. This step was repeated to amplify the amount of C3b deposited. To assemble iC3b-organism complexes, aliquots of the C3b-organism suspensions were washed and resuspended with purified human complement factors H (20 mg) and/or I (5 mg) (Advanced Research Technologies) in HBSS ϩϩ and incubated at 37ЊC for 20 min. We used N. gonorrhoeae isolate 15253 [18] because it is an avid factor H binder [13] and completely converts C3b to iC3b in the presence of factors H and I. The organisms were pelleted and the supernatants discarded. C3b-and iC3b-labeled gonococci were then probed with the three anti-C3 component MAbs (above), and flow cytometry [27] and whole cell ELISA (see below) were done. Efficiency of deposition of C3b and iC3b on the organisms was verified by concomitant SDS-PAGE autoradiography using 125 I-C3. Whole cell ELISA-determination of complement and immunoglobulin molecules bound to gonococci in vitro. Measurements of complement and immunoglobulin molecules bound to gonococci, after opsonization in NHS, were made by a modification [28, 29] of a kinetic ELISA [30, 31] essentially as described previously [27] . Log-phase gonococci (10 8 organisms/mL) were incubated in gel-HBSS ϩϩ containing either 10% PNHS or 10% heat-inactivated PNHS in microcentrifuge tubes (total volume, 100 mL; 10 min; 37ЊC; shaking water bath). The 10% serum concentration was chosen for incubation because it represents the approximate concentration of complement components and total complement hemolytic activity in cervical secretions [32] . Detection was achieved with alkaline phosphatase-conjugated antibodies directed against the complement component followed by the addition of substrate. The number of molecules bound per organism was determined by use of the following equation:
Ig ϭ immunoglobulin Nucleophilic release of ester-bound C3 fragments from gonococci by methylamine. The molecular form of 125 I-C3 deposited on the gonococci was determined by incubation with the nucleophile methylamine. Methylamine disrupts the O-ester bond between the a chain of C3 and the acceptor, thereby releasing the ester-bound forms of C3 into the supernatant. After counting gamma emissions, one pellet was solubilized in 20 mL of 1% SDS for 10 min at 100ЊC, followed by addition of 4 mL of 200 mM methylamine in carbonate buffer at pH 11, and then incubated for 1 h at 37ЊC [8] . A duplicate, untreated pellet was mixed with SDS sample buffer containing 90 mM dithiothreitol before 7.5% SDS-PAGE. Autoradiography was done on dried gels by use of Kodak X-Omat AR radiographic film and Quanta III intensifying screens (DuPont, Wilmington, DE) at Ϫ80ЊC. Equal numbers of counts were loaded per lane. In selected cases, Western blots were done using anti-C3 reagents as probes [33] .
Organism-capture ELISA-determination of complement and immunoglobulin molecules bound to gonococci in vivo. First, 1 SS gonococcal isolate (24-1) and 4 SR gonococcal isolates (WG, 8551, NRL 31797, and NRL 31800) were grown to log phase (optical density [OD] at 600 nm of 0.2) in liquid media and labeled with 125 I [34] for standardization of the assay. Next, standard curves relating OD to concentration of each complement component and immunoglobulin were generated by linear regression analysis [35] of OD readings generated in an ELISA [31] , in which increasing known concentrations of the antigen (C3, C3b, iC3b, C4, factor B, IgG, IgA, or IgM) were captured in wells coated with the appropriate antibodies. Detection was achieved with alkaline phosphatase-conjugated antibodies directed against the complement component or immunoglobulin of interest. Next, measurement of complement components and immunoglobulins bound to gonococci in infected secretions (cervical lavage fluids) was done by use of an organism-capture ELISA that employs MAb 2C3-coated polystyrene sticks [36] followed by measurement of specific complement or immunoglobulin components on captured gonococci. Number of molecules bound per organism was determined with the same formula used in the whole cell ELISA.
Statistical analysis. A three-factor factorial analysis of variance was used to examine differences due to sialylation, controlling for Por subclass [35] . Because the data were slightly unbalanced with respect to Por, the regression approach to analysis of variance was used [37] . An initial analysis examined potential interaction between sialylation and Por subclass. If no interaction was found, the interaction term was dropped from the model. Because there was slight skewing of the iC3b/C3 ratio data in vivo, a log transformation was done before analysis of this variable.
Results

Differential sialylation of SS and stably SR gonococci.
Growth of gonococci in media containing CMP-NANA led to gonococcal sialylation and routinely converted SS gonococci to SR gonococci in concomitant bactericidal assays (data not shown). 0.47 ‫ע‬ 0.05 ϫ 10 obtained when sialylation of LOS was assessed by tricine SDS-PAGE fluorography (not shown), indicating that SR isolates either express less of the 4.6-kDa 3F11 sialic acid acceptor site [38] or have a different acceptor site(s) in their LOS.
Specificity of anti-iC3b and -C3b MAbs. Anti-iC3b neoantigen MAb [24] , anti-iC3b MAb G-3E [23] , and anti-C3b MAb C-5G [23] were all initially selected for their ability to differentiate between iC3b and C3b deposited on erythrocyte surfaces. The anti-iC3b neoantigen MAb has been reported to lose specificity for iC3b bound to nonerythrocyte surfaces, an effect postulated to be due to the absence of C3b-binding proteins on such surfaces [39] . Anti-C3b MAb C-5G is reported to bind strongly with C3b-erythrocytes and weakly with iC3b-erythrocytes, while anti-iC3b MAb G-3E is specific for degraded, inactive C3 products (iC3b, C3dg, and C3d) bound to erythrocytes [23] . We determined the specificities of these MAbs by first depositing C3b on gonococci with CVF,Bb and C3 to ensure deposition of pure C3b (in the absence of iC3b) only and then converting C3b to iC3b with factors H and I [13] . Successful deposition of only C3b and only iC3b were established with parallel experiments using 125 I-C3 and SDS-PAGE . Serum-resistant isolate 15253 was incubated with purified human C3 and preformed cobra venom factor,Bb convertase to deposit C3b (15253-C3b). These complexes were incubated with purified human factors I and H to completely convert C3b to iC3b (15253-iC3b). At left, gonococci alone (15253) or opsonized (15253-C3b and 15253-iC3b) were probed with anti-iC3b neoantigen MAb (anti-iC3b neo), anti-iC3b MAb G-3E, or anti-C3b MAb C-5G, and median fluorescence was determined (50,000 events counted). At right (whole cell ELISA), gonococci alone (15253) and opsonized gonococci were probed with same MAbs. figure  1 ), flow cytometry indicated that both the iC3b neoantigen MAb and anti-iC3b MAb G-3E were specific for iC3b-gonococci complexes, while anti-C3b MAb C-5G bound to both C3b-gonococci and iC3b-gonococci. In whole cell ELISA, however, the iC3b neoantigen MAb showed some recognition of C3b, whereas both anti-C3b MAb C-5G and anti-iC3b MAb G-3E were specific for their respective antigenic targets. Kinetics of total C3 binding on gonococci using radiolabeled C3. We measured total C3 bound to two prototypic gonococcal isolates, 1 SS (24-1, cervical isolate from pelvic inflammatory disease) and 1 stably SR (252, asymptomatic cervical infection), directly after opsonization in PNHS supplemented with radiolabeled C3. Because sialylation of stably SR isolates was minimal (∼5% as much as SS isolates) and has no effect on total C3 binding to SR isolates (see below), radiolabeled C3 experiments were done with sialylated and nonsialylated SS (24-1 isolate) and nonsialylated SR (252 isolate) gonococci. With use of radiolabeled C3, the SR isolate 252 bound fewer total molecules of C3 per organism than did either variant of 24-1 at all time points up to 60 min of opsonization (figure 2). While both 24-1 and sialylated 24-1 (24-1NANA) bound equivalent amounts of total molecules of C3 per organism until 10 min, sialylation diminished total C3 binding at later time points. Similar results were obtained with a kinetic ELISA using polyclonal anti-C3 antibody (not shown), indicating that sialylation decreased total C3 antigen binding to levels comparable to those seen on SR isolate 252.
Determination of kinetics of C3 processing on gonococci by use of radiolabeled C3. The strong nucleophile methylamine can disrupt the covalent ester bond formed between the a chain of C3 and acceptor surfaces, thereby releasing C3 fragments into the supernatant (figure 3). The amide bond between C3 fragments and acceptor sites is resistant to such nucleophilic attack [7, 40] . The 125 I-C3 fragments released by methylamine and those still bound to gonococcal membrane fragments were analyzed by 7.5% SDS-PAGE autoradiography under reducing conditions (figure 4). Under these conditions, the disulfide bond linking the a and b chains and the disulfide bond linking the a 1 and a 2 chain fragments (figure 3) are reduced. In the C3 control lanes ( figure 4) , a 47-kDa band is apparent, which represents an autolytic fragment caused by denaturation of untreated C3 in SDS-containing sample digestion buffer, reflecting the presence of an intact thiolester bond [41] and ensuring that the C3 preparation is active.
The kinetics of C3 processing were strikingly different for each of the 3 isolates. Figure 4A depicts early (at 5 and 10 min of opsonization) binding of ester-linked C3b (110-kDa a band released by methylamine) and rapid processing to iC3b (68-kDa a 1 band released) on SS isolate 24-1 coupled with persistence of C3b (prominent 110-kDa a band released) through ) from 1 representative experiment, done in duplicate. mean ‫ע‬ SD 10 min of opsonization. In addition, high-molecular-mass bands, above the 110-kDa a band, were present at both early time points. Anti-C3b MAb C-5G, which was originally prepared and selected for recognition of C3b bound to erythrocytes [23] , does not recognize C3b after disulfide bond reduction and denaturation in SDS-PAGE (data not shown) and was used in whole cell ELISAs only (see below). Parallel (at 5 and 10 min of opsonization) Western blots of SS isolate 24-1 were probed with the anti-iC3b MAb G-3E [23] , which does recognize bound iC3b in these conditions (see below). No binding of MAb G-3E to high-molecular-mass bands was detected at 5 min, but binding was detected at 10 min (not shown). This result is consistent with C3b amide bound to gonococcal membrane acceptors that is converted to iC3b as the incubation proceeds. The C3 present on SS isolate 24-1 was completely degraded to iC3b over the 60-min opsonization period. Sialylation of this isolate (24-1NANA; figure 4B ) markedly changed C3 processing. All of the C3 present was ester-linked (released by methylamine) and processed immediately to iC3b, as evidenced by virtual absence of the 110-kDa a band coupled with appearance of the 68-kDa a 1 band at 5 min of opsonization.
SR isolate 252 ( figure 4C ) processed C3 more slowly than did SS isolate 24-1. For the 5-min opsonization time point, mostly a and b bands compatible with nonspecifically associated C3 were present, despite identical methods of opsonization and harvesting of pellets for all 3 isolates (this nonspecific binding seen at 5 min was observed repeatedly with this isolate, but was absent in the 2 variants of isolate 24-1). Nevertheless, a small amount of the 68-kDa a 1 band was seen at 5 min (in the absence of the 110-kDa a band) and probably represents complete conversion of C3b to iC3b at this initial time point ( figure  4C ). High-molecular-mass bands were also present but appeared later and lasted longer during the opsonization period than did those seen with SS isolate 24-1. Parallel Western blots of SR isolate 252 (at 5 and 10 min of opsonization) that were probed with anti-iC3b MAb G-3E demonstrated binding to high-molecular-mass bands (not shown), consistent with iC3b that is amide-bound to gonococcal membrane fragments. Almost all of the C3 bound to all three variants had been processed to iC3b by 60 min of opsonization.
ELISA determination of kinetics of C3 processing on gonococci. Methylamine is unable to displace amide-bound C3 fragments from acceptor surfaces [7, 29, 40, 43] . Direct determination of the specific amide-bound C3 fragments is difficult because they cannot be separated from acceptor surfaces without altering their primary structure. Therefore, the presence of C3 fragments amide-bound to acceptor surfaces can only be inferred. To quantitate C3b and iC3b bound to gonococci during the 60-min opsonization period, we used MAbs that recognize iC3b and C3b [23] in whole organism ELISA. This tech- Figure 3 . Methylamine releases ester-bound C3b and iC3b from acceptor surfaces. C3a (10-kDa) fragment is cleaved from 120-kDa a chain by C3 convertase as C3b binds to acceptor surface. O-linked ester bond formed between thiolester site in C3 a chain and OH groups of surface acceptor molecules is susceptible to disruption by strong nucleophiles such as methylamine. N-linked amide bond between C3 and acceptor sites is resistant to such nucleophilic attack [7, 40] ; thus, C3 fragments that are amide-bound will not be displaced by methylamine. Incubation of organisms that have fixed C3 through ester bonds will, during incubation with methylamine under appropriate conditions, liberate C3 fragments into supernatants for further analysis. In case of C3b, a (110-kDa) and b (75-kDa) chains are released. When iC3b is present, a 1 (68-kDa) and a 2 (43-kDa) fragments along with b (75-kDa) are released. I-labeled C3 at 37ЊC. Aliquots were removed at intervals of 5, 10, 30, and 60 min (shown at top of lanes), washed free of nonassociated 125 I-labeled C3, and incubated with 200 mM methylamine in 1% SDS for 60 min at 37ЊC to liberate ester-linked C3 fragments from gonococcal membrane acceptors. Entire mixtures were subjected to 7.5% SDS-PAGE under reducing conditions (equal counts loaded per lane), followed by autoradiography. Molecular weight standards are shown at left. Lanes marked "C3" contain labeled C3; 120-kDa a and 75-kDa b chains are seen along with 47-kDa band that represents autolytic fragment caused by denaturation of untreated C3 in SDS-containing sample digestion buffer, reflecting presence of intact thiolester bond [41] and ensuring activity of C3. Positions of released 110-kDa a chains of C3b and 68-kDa a 1 chains of iC3b are shown at right; 43-kDa a 2 band of iC3b is not apparent in these autoradiograms because it is not well iodinated in C3 labeled with Iodobeads [42] . A, Serum-sensitive isolate 24-1; B, phenotypically serumresistant isolate 24-1NANA (grown in presence of 5 -monophospho-N-acetyl neuraminic acid); C, stably serum-resistant isolate 252.
nique indicated that at 5 and 10 min of opsonization, almost all of the C3 antigen bound to SS isolate 24-1 was C3b ( figure  5A ). By use of radiolabeled C3, the released 68-kDa a 1 band of ester-linked iC3b had also been shown (above) to be present at these early opsonization time points (figure 4A), while minimal iC3b was measured in the ELISA (figure 5A). The marked excess of C3b bound to isolate 24-1 at these early time points (also reflected by both ester-and possibly amide-linked C3b at 5-and 10-min time points in the autoradiogram shown above [ figure 4A ]) may have obscured recognition of a small amount of iC3b that could be more easily recognized by the more sensitive autoradiographic technique that physically separates the different molecular species. By 30 min of opsonization, this C3b had been converted predominantly to iC3b ( figure 5A ). In contrast, a small amount of C3b was present at 10 min on SR isolate 252 (figure 5C), and it was processed to iC3b more quickly (by 10 min and beyond of opsonization; figure 5C ). Sialylation of 24-1 resulted in C3 that was immediately processed to iC3b after opsonization in serum (figure 5B), findings that were identical to those shown in the autoradiogram (exclusively ester-bound C3; figure 4B ).
Collectively, these data indicated that in PNHS, SS isolate 24-1 bound C3 antigen through ester and possibly amide linkages. Although much of C3b was converted rapidly to iC3b, a significant portion remained stable as C3b over the first 30 min of opsonization. Sialylation reproducibly converted 24-1 to a phenotypic SR isolate and markedly decreased total C3 binding. In addition, C3b was exclusively ester-bound and was processed to iC3b earlier in the kinetic opsonization period on 24-1NANA than on the nonsialylated 24-1. In contrast, kinetics of C3 antigen binding to the SR isolate 252 were delayed. Less total C3 antigen was bound, and maximal binding of C3 antigen occurred later in the opsonization period. Once bound, C3b was promptly processed to iC3b, much of which may have been amide-bound to the organism.
Effect of sialylation on alternative complement pathway regulation during in vitro incubation of gonococci in NHS.
To extend the findings generated using prototypic gonococcal isolates, we next used ELISA to examine complement binding on the 16 clinical (8 SS and 8 SR) isolates after incubation (10 min) in fresh PNHS. Sialylation of SS gonococci in vitro decreased total C3 antigen bound 4.6-fold, to levels commensu- Figure 5 . Kinetics of C3b processing determined by ELISA. Gonococci were incubated in 10% pooled normal human serum. Aliquots were removed at various intervals up to 60 min, organisms were washed, and amounts of C3b and iC3b bound to organisms was determined by ELISA using monoclonal antibodies (MAbs) directed against C3b (MAb C-5G) and iC3b (MAb G-3E) [23] . rate with those bound by both sialylated and nonsialylated SR gonococci (figure 6; ). Overall, the level of C3b bound P ! .001 on SR gonococci was 20% of that on SS gonococci ( ). P ! .001 Sialylation of SS gonococci decreased C3b bound by 96% ( ) while having no effect on SR gonococci. SR gono-P ! .001 cocci bound 33% more iC3b than did SS gonococci (P ϭ ), while sialylation did not affect total iC3b bound. These .031 differences were reflected in changes of the median iC3b/C3 ratio on SS gonococci from 0.21 (not sialylated) to 1.1 (sialylated) ( ; figure 7A) . Growth in the presence of CMP-P ! .001 NANA did not affect the median iC3b/C3 ratio on SR isolates (both 1.1). Mirroring the effects seen with C3, the amount of factor B bound was decreased by sialylation of SS isolates and was lower on SR isolates as a whole (  ; table 1 ). This P ! .001 latter effect was similar to the factor B differences seen on the isolates in vivo (see below).
Relative amounts of total C3, iC3b, and factor B bound to gonococci in vivo. Mean values from four separate experiments conducted with each 125 I-labeled isolate (24-1, WG, 8551, NRL 31797, and NRL 31800) were determined and used to generate a standard curve relating OD to colony-forming units by linear regression ( ). With nonradiolabeled organisms, r ϭ .98 OD values per stick were compared to colony-forming units for 1 of the SS isolates (8551) along with 4 additional SR isolates (71H, JW31, NRL 32065, and group II-no. 45). A 10% organism-capture ratio was observed with both methods. These results reflect stable expression of the H.8 lipoprotein antigen across 5 individual gonococcal isolates in this assay. Gonococci and gonococcal membrane fragments were captured directly onto MAb 2C3-coated polystyrene sticks from infected cervical secretions of the same 16 asymptomatic women, followed by detection with horseradish peroxidase-conjugated MAb 2C3, polyclonal anti-C3, anti-iC3b neoantigen MAb, or polyclonal anti-factor B. Data were initially analyzed and found to be slightly unbalanced with respect to Por subclass; therefore, the regression approach to analysis of variance was used to control for the effect of Por [35] . SS gonococci bound one-third more total C3 antigen in vivo than did SR gonococci, but the difference was not statistically significant ( ). In contrast, P ϭ .488 the total iC3b bound to SR gonococci was 1.7 times higher than that bound to SS gonococci ( ). The iC3b/C3 ratio P ϭ .058 was also higher on SR than SS gonococci ( ; figure 7B) . P ϭ .071 SS gonococci/membrane fragments captured in vivo bound 3.8 times more factor B than did SR gonococci ( ; table P ϭ .062 1).
Immunoglobulin binding in vitro and in vivo to gonococci. Levels of IgG, IgM, and IgA bound to the clinical isolates were determined. After in vitro opsonization with NHS, SS isolates bound significantly more ( ) IgM than did stably SR P ! .001 isolates. SS isolates bound almost twice as much IgM as did SR isolates in vivo, but the difference was not statistically significant (  ; table 2 ), which could reflect a limiting amount P ϭ .17 of IgM present in cervical secretions. IgG and IgA binding was identical across phenotypes in both settings (not shown). These findings are consistent with prior observations that in NHS, anti-LOS IgM binds better to SS than to SR isolates [44, 45] , and indicate that the same effect occurs in genital secretions. Immunoglobulin binding was not significantly decreased by in vitro sialylation.
Classical complement pathway activation in vitro and in vivo. The amount of C4 bound was determined to assess the involvement of the classical pathway in complement activation on gonococci. In vitro, total C4 binding was significantly decreased on SR ( ) and sialylated SS ( ) isolates P ! .001 P ! .001 (table 3) . The amount of C4 bound in vivo to SR isolates was about half that bound to SS isolates, but the difference was not significant ( ). The decrease in C4 bound by the P ϭ .44 sialylated SS isolates, while maintaining equivalent amounts of antibody (including IgM) bound, may implicate sialylation as a regulatory factor in the classical complement pathway. The mechanism for such regulation remains to be determined.
Discussion
To better define mechanisms underlying the correlation of sensitivity to in vitro killing by NHS (nonimmune) with the severity of local inflammation in gonococcal infection [3] , investigators have focused on complement processing at the level of C3 [6, 9] . Despite this correlation, in vitro sialylation of the LOS of SS gonococci [19] confers phenotypic serum resistance to these isolates. However, gonococci appear to be heterogeneously sialylated at the mucosal level [10] . Prior investigations have reported in vitro C3 binding and fragmentation data at late time points of opsonization [6, 9, 46] . We examined early kinetics of C3b deposition and processing, because these events likely relate more directly to pathogenesis of the resultant clinical syndromes. In addition, we correlated these data with observations made on gonococci at the cervical level in vivo.
The kinetics and magnitude of C3 antigen binding in vitro for three prototypic gonococcal variants were studied first. SS isolate 24-1 bound substantially more total C3 antigen than did either of the 2 prototypic SR phenotypes at all opsonization time points (figure 2). C3b was present early (up to 10 min) on 24-1 but appeared to be processed thereafter to iC3b as reported previously [6] . The magnitude of C3b bound early, combined with a low iC3b/C3 ratio common to most SS isolates (figure 7), likely drives rapid membrane attack complex (MAC) formation on the surface of such isolates. C3b bound to SS isolate 24-1 was eventually processed fully to iC3b. Therefore, early persistence of C3b on SS isolate 24-1 was more likely due to the 3-fold increase in total C3 antigen bound (compared to stably SR isolate 252) than to increased stability of amidebound C3b [47] . Even as it is being processed to iC3b, a favorable ratio of C3b to iC3b may allow for additional deposition of C3b (by creating the alternative pathway C3 convertase, C3b,Bb) and continued expression of C3b function.
Stably SR isolate 252 exhibited strikingly different kinetics of C3 processing. At 10 min of opsonization, a minute amount of C3b was detected (figure 4C), and the majority of C3b had been processed already to iC3b. Stably SR isolate 252 directly binds a significant amount of factor H [13] , while SS isolate 24-1 binds factor H only after sialylation of its LOS [27] . These ) and was significantly increased ( ) on SS gonococci that were sialylated P ϭ .071 P ! .001 in vitro. differences in the amount and site of factor H binding may in turn have influenced the degree to which C3b was likely to have been degraded to iC3b. Therefore, the more rapid phagocytosis of SS gonococci previously reported in vitro [5] could also be attributed to an increase in the total amount of the iC3b opsonin generated. Both SS and stably SR gonococcal isolates have been reported to display more iC3b than C3b at late opsonization time points [6, 9, 46] . At these opsonization time points, all three variants appeared to have converted C3b predominantly to iC3b on their surfaces (figure 4, 60-min lanes). However, the stably SR isolate (252) bound C3b more slowly than did either variant of 24-1. This observation is consistent with different lag phases in C3b deposition observed on different activator surfaces, including those reported using different isolates of Escherichia coli [48] . Although 252 and 24-1NANA bound about the same number of molecules of C3 per organism (figure 2) that was processed primarily to iC3b (figures 4 and 5), there may have been differences in the type (ester vs. amide) of linkage to acceptor sites. Stably SR isolate 252 bound C3 seemingly through a mixture of amide and ester bonds (figure 4C). 24-1NANA bound C3 exclusively through ester linkages (figure 4B), and in contrast to 24-1, C3b bound to 24-1NANA was quickly converted to iC3b. Sialylation, in addition to decreasing the magnitude of C3 binding, appears to cause C3b to bind exclusively through ester links to membrane targets. The differences in C3 covalent binding observed may implicate distinct acceptor sites on the two gonococcal phenotypes, although our current investigations do not directly address their identity. More important, factor I-mediated conversion to iC3b is facilitated by the proximity of surface-bound factor H or sialic acid [27] to ester-linked C3b molecules. Together these effects combine to produce major differences in stability of C3b.
We next focused on early complement activation events by use of 16 (8 SS and 8 stably SR) clinical isolates that were passaged in vitro, incubated in PNHS for 10 min, and then probed for complement fragments. SS gonococci bound five times more total C3 antigen and C3b (figure 6) and three times more factor B (table 1) than did SR gonococci. Conversely, SR gonococci bound 33% more iC3b than did SS gonococci at this time point. Sialylation of SS isolates in vitro yielded phenotypic serum resistance, reduced total C3 antigen bound 4-fold and total C3b bound by 96% ( figure 6; ), and significantly P ! .001 ( ) increased the percentage of C3 antigen bound as iC3b P ! .001 (iC3b/C3 ratio; figure 7) . A similar effect occurs on the surface of sialylated Trypanosoma cruzi trypomastigotes [49] . Sialylation also greatly decreased total factor B bound by SS isolates to a level comparable to that seen on SR isolates ( ; P ! .001 table 1). However, sialylation did not change total IgM (table  2) or other immunoglobulins bound, similar to prior observations made with rabbit anti-gonococcal Por antibody [50] . Therefore, decreased total C3 antigen binding (figure 6) observed in association with sialylation of SS gonococci likely represented a loss of the alternative pathway C3b feedback amplification loop due to direct binding of factor H by sialylated LOS, as we have recently reported [27] .
To correlate our in vitro findings with complement activation at the cervical level, gonococci and gonococcal membrane fragments were captured directly from genital secretions and probed for bound complement components. To our knowledge, the capture technique that we used represents the first report of complement and immunoglobulin binding to organisms in vivo. Molecules of C3 measured (∼10 5 -10 6 molecules/organism) in our ELISA correlated well with quantitation of radiolabeled C3 when bacteria are incubated in serum [42, 51, 52] . We observed that in the local genital milieu, SR gonococci bound less total C3 antigen but slightly more iC3b ( ) than did SS P ϭ .058 gonococci, leading to an increased iC3b/C3 ratio ( ; P ϭ .071 figure 7 ). Although the median iC3b/C3 ratios on SS gonococci were similar in vitro and in vivo (figure 7), there was a wider range in values observed in vivo than in vitro. This discrepancy may reflect prolonged exposure of in vivo isolates to the complement cascade, thereby favoring processing of C3b more fully to iC3b [10] and more total C3 antigen bound to SS than to SR gonococci. In addition, decreased specificity of the antiiC3b neoantigen MAb (figure 1) when used in whole cell ELISA and heterogeneous sialylation of SS isolates in vivo [10] may also have diminished potential differences in total C3 binding and processing. Nevertheless, the remaining differences approached statistical significance. C3b was not measured in vivo because these organisms were all likely to have been opsonized in vivo for far longer time periods than were those measured in vitro. Factor B was therefore measured as a surrogate for C3b, because factor B binds to sites on C3b in addition to those displaced by factor H [53] , the latter together with factor I, resulting in cleavage of C3b to iC3b [54] . SS isolates bound 4-fold more factor B in vivo than did SR isolates ( ; table P ϭ .062 1).
SS gonococci are known to evoke a predominantly IgM bactericidal response [44, 45] and also bind to IgM in NHS. In contrast, SR gonococci elicit predominantly IgG antibodies [15, 55] . However, measurements of immunoglobulins bound to gonococci at the genital level have not previously been reported. SS gonococci bound almost twice as much IgM in vivo as did SR gonococci. Although this difference was not statistically significant (  ; table 2 ), comparable experiments in vitro P ϭ .17 showed a 3-fold increase in IgM bound to SS gonococci, a difference that was not changed by sialylation ( ; table P ! .001 2). IgA and IgG amounts bound, both in vivo and in vitro, were not significantly different between SS and SR gonococci. Sialylation, in vitro, had no effect on binding of any of the three immunoglobulin classes. These findings provide support for the concept that the specific humoral immune response may cross into and contribute at the local mucosal milieu, which has particular relevance in the context of vaccine development [56] .
Finally, we assessed activity of the classical complement pathway in relation to sialylation status. As expected, SR isolates bound less total C4 than did SS isolates. Interestingly, sialylation significantly decreased C4 binding in vitro (
; table P ! .001 3) without a concomitant decrease in IgM binding. Sialic acid-mediated classical pathway inhibition is likely indirect and achieved through one or more potential mechanisms. Others have observed that although LOS sialylation does not change total IgM bound, the amount of IgM required to produce 50% killing increases with the amount of CMP-NANA used for sialylation [57] . Increased binding of factor H to sialylated LOS [27] may decrease "feedback" activation through the ability of factor H to restrict classical pathway activation [58] . Sialylation could potentially increase binding of classical pathway-specific regulatory molecules, although this does not seem to be the case for C4-binding protein (unpublished data) [57, 59] . Alternatively, sialylated LOS may bind other serum proteins, such as vitronectin, which binds heparin and inhibits formation of the terminal MAC through two separate domains [60] . Heli-cobacter pylori has been shown to bind vitronectin through sialylated surface proteins [61] . Interestingly, vitronectin mediates gonococcal invasion of Chinese hamster ovary [62] and HeLa cell [63] lines through binding to OpaA protein. The relationship between sialylation and classical pathway inhibition will require future investigation.
